Prospective Evaluation of Idiopathic Pancreatitis: Role of Endoscopic Ultrasonography

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
University of Alabama at Birmingham
ClinicalTrials.gov Identifier:
NCT00609726
First received: January 24, 2008
Last updated: January 21, 2016
Last verified: January 2015
  Purpose
The purpose of the study is to determine the best evaluation for patients with idiopathic (unexplained) pancreatitis.

Condition
Gallbladder Disease
Pancreatitis

Study Type: Observational
Study Design: Observational Model: Case Control
Time Perspective: Prospective
Official Title: Prospective Evaluation of Idiopathic Pancreatitis: Role of Endoscopic Ultrasonography

Resource links provided by NLM:


Further study details as provided by University of Alabama at Birmingham:

Primary Outcome Measures:
  • Evaluation of current clinical practice for patients with idiopathic pancreatitis [ Time Frame: 3 hours ] [ Designated as safety issue: No ]

Enrollment: 199
Study Start Date: December 2015
Study Completion Date: December 2015
Primary Completion Date: December 2015 (Final data collection date for primary outcome measure)
Detailed Description:
The study evaluates the role of endoscopic ultrasonography, given that the minimally invasive procedures can diagnosis gallbladder disease as well as pancreatitis abnormalities.
  Eligibility

Ages Eligible for Study:   19 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population
Men and women diagnosed with unexplained pancreatitis.
Criteria

Inclusion Criteria:

  • All patients referred to the principal investigator for unexplained pancreatitis will be enrolled.

Exclusion Criteria:

  • There are no gender nor racial exclusion.
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00609726

Locations
United States, Alabama
University of Alabama
Birmingham, Alabama, United States, 35294
Sponsors and Collaborators
University of Alabama at Birmingham
Investigators
Principal Investigator: Charles M Wilcox, M.D. University of Alabama at Birmingham
  More Information

Responsible Party: University of Alabama at Birmingham
ClinicalTrials.gov Identifier: NCT00609726     History of Changes
Other Study ID Numbers: X040909004  228552 
Study First Received: January 24, 2008
Last Updated: January 21, 2016
Health Authority: United States: Institutional Review Board

Keywords provided by University of Alabama at Birmingham:
Endoscopic Ultrasonography
Pancreatitis
EUS

Additional relevant MeSH terms:
Gallbladder Diseases
Pancreatitis
Biliary Tract Diseases
Digestive System Diseases
Pancreatic Diseases

ClinicalTrials.gov processed this record on May 02, 2016